Skip to content

Drug interactions

Elagolix + Rabeprazole

Severity: Minor

Elagolix and Rabeprazole: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a weak CYP2C19 inhibitor and a weak-to-moderate CYP3A inducer, so it could change rabeprazole exposure in either direction. Because rabeprazole is cleared largely non-enzymatically, any effect is expected to be small.

What this interaction means in plain words

Elagolix and Rabeprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Elagolix belongs to Musculoskeletal; Rabeprazole belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Elagolix weakly inhibits CYP2C19 and induces CYP3A4, both minor routes for rabeprazole.

What to do

No dose adjustment is routinely needed; monitor for changes in reflux control.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Rabeprazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Rabeprazole?

MediHelp rates the interaction as minor. Elagolix and Rabeprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Elagolix is a weak CYP2C19 inhibitor and a weak-to-moderate CYP3A inducer, so it could change rabeprazole exposure in either direction. Because rabeprazole is cleared largely non-enzymatically, any effect is expected to be small.

How serious is the interaction between Elagolix and Rabeprazole?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is routinely needed; monitor for changes in reflux control.

What other medicines interact with Rabeprazole?

MediHelp also lists interactions of Rabeprazole with, for example, Rilpivirine, Acalabrutinib, Atazanavir. The full list is on the Rabeprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in